# Skin Barrier and Microbiome of CTCL Patients

> **NCT05827107** · — · COMPLETED · sponsor: **Centre for Human Drug Research, Netherlands** · enrollment: 43 (actual)

## Conditions studied

- Lymphoma, T-Cell, Cutaneous

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05827107
- **Lead sponsor:** Centre for Human Drug Research, Netherlands
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-03
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827107, "Skin Barrier and Microbiome of CTCL Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05827107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*